Vor Biopharma Inc.
VOR
$16.10
$1.177.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 491.53M | 455.21M | 170.46M | 200.57M | 60.04M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.39M | 1.15M | 747.00K | 1.50M | 4.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.86M | 1.75M | 1.28M | 2.86M | 297.00K |
| Total Current Assets | 500.78M | 458.11M | 172.49M | 204.93M | 64.85M |
|
|
|||||
| Total Current Assets | 500.78M | 458.11M | 172.49M | 204.93M | 64.85M |
| Net Property, Plant & Equipment | 3.39M | 3.47M | 3.31M | 24.00K | 39.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.58M | 2.55M | 437.00K | 420.00K | 4.78M |
| Total Assets | 506.75M | 464.13M | 176.24M | 205.37M | 109.31M |
|
|
|||||
| Total Accounts Payable | 1.04M | 5.13M | 885.00K | 669.00K | 3.73M |
| Total Accrued Expenses | 14.73M | 19.76M | 17.70M | 58.10M | 8.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 307.00K | 280.00K | 252.00K | -- | 4.27M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 44.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 44.00K |
| Total Current Liabilities | 16.08M | 25.17M | 18.84M | 58.77M | 16.73M |
|
|
|||||
| Total Current Liabilities | 16.08M | 25.17M | 18.84M | 58.77M | 16.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.63M | 2.72M | 2.81M | -- | 26.52M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 638.46M | 600.55M | 2.38B | 1.65B | -- |
| Total Liabilities | 657.17M | 628.44M | 2.40B | 1.71B | 43.24M |
|
|
|||||
| Common Stock & APIC | 1.22B | 988.62M | 650.33M | 557.44M | 555.53M |
| Retained Earnings | -1.37B | -1.15B | -2.88B | -2.06B | -489.48M |
| Treasury Stock & Other | -706.00K | 41.00K | 12.00K | 14.00K | 23.00K |
| Total Common Equity | -150.42M | -164.31M | -2.23B | -1.51B | 66.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -150.42M | -164.31M | -2.23B | -1.51B | 66.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -150.42M | -164.31M | -2.23B | -1.51B | 66.07M |
|
|
|||||